Both cell-surface and secreted CSF-1 expressed by tumor cells metastatic to bone can contribute to osteoclast activation

K Yagiz, SR Rittling - Experimental cell research, 2009 - Elsevier
K Yagiz, SR Rittling
Experimental cell research, 2009Elsevier
Tumors metastatic to the bone produce factors that cause massive bone resorption mediated
by osteoclasts in the bone microenvironment. Colony stimulating factor (CSF-1) is strictly
required for the formation and survival of active osteoclasts, and is frequently produced by
tumor cells. Here we hypothesize that the CSF-1 made by tumor cells contributes to bone
destruction in osteolytic bone metastases. We show that high level CSF-1 protected
osteoclasts from suppressive effects of transforming growth factor β (TGF-β). r3T cells, a …
Tumors metastatic to the bone produce factors that cause massive bone resorption mediated by osteoclasts in the bone microenvironment. Colony stimulating factor (CSF-1) is strictly required for the formation and survival of active osteoclasts, and is frequently produced by tumor cells. Here we hypothesize that the CSF-1 made by tumor cells contributes to bone destruction in osteolytic bone metastases. We show that high level CSF-1 protected osteoclasts from suppressive effects of transforming growth factor β (TGF-β). r3T cells, a mouse mammary tumor cell line that forms osteolytic bone metastases, express abundant CSF-1 in vitro as both a secreted and a membrane-spanning cell-surface glycoprotein, and we show that both the secreted and the cell-surface form of CSF-1 made by r3T cells can support osteoclast formation in co-culture experiments in the presence of RankL. Mice with r3T bone metastases have elevated levels of both circulating and bone-associated CSF-1, and the majority of CSF-1 found in bone metastases is associated with the tumor cells. These results support the idea that tumor-cell produced CSF-1 contributes to osteoclast development and survival in bone metastasis.
Elsevier